Skip to main content
November 19, 2013
Source - Seattle P-I
In a clinical trial spanning 45 sites across the country, researchers at Seattle Children’s will tackle one of the hard-to-beat complications that strikes the lungs of cystic fibrosis patients and others. The culprit is a bacterium that once it gets started growing in damaged lungs of CF patients, or others with severe burns or immunodeficiencies, it keeps coming back and causing trouble.
Parental decisions are the bedrock of childhood vaccination rates. While most parents turn to their pediatricians for help ... cont.
Dr. Tim Rose, co-director of Seattle Children’s Research Institute’s Center for Global Infectious Disease Research, has ... cont.
Although many advances have been made in temporary heart pumps for adults, the same has not been true for children. But, that’s ... cont.
Seattle Children’s provides healthcare for the special needs of children regardless of race, color, creed, national origin, religion, sex (gender), sexual orientation or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.
© 1995-2014 Seattle Children’s Hospital, Research and Foundation